Acumen Pharmaceuticals, Inc.
ABOS
$1.11
$0.098.82%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -14.37% | -23.08% | 3.15% | 3.69% | 13.04% |
| Total Receivables | 96.87% | 200.94% | -43.92% | -52.75% | 140.96% |
| Inventory | 11.19% | 18.18% | -2.42% | 26.53% | 46.27% |
| Prepaid Expenses | -15.13% | 964.21% | -76.89% | -49.07% | -33.63% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -12.24% | -4.98% | 135.88% | 45.13% | 4.26% |
| Total Current Assets | -14.12% | -22.21% | 4.33% | 3.74% | 12.82% |
|
|
|||||
| Total Current Assets | -14.12% | -22.21% | 4.33% | 3.74% | 12.82% |
| Net Property, Plant & Equipment | -11.95% | -10.47% | -8.51% | -6.56% | 302.40% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -1.08% | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -6.65% | -14.71% | 27.96% | -18.06% | 20.11% |
| Total Assets | -10.48% | -7.59% | -4.01% | -2.95% | 8.29% |
|
|
|||||
| Total Accounts Payable | 141.16% | -44.38% | 36.77% | 123.28% | 1.25% |
| Total Accrued Expenses | 25.25% | 58.45% | 127.13% | -54.43% | 125.96% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 3.10% | 3.20% | 3.31% | -86.03% | 43,200.00% |
| Total Finance Division Other Current Liabilities | 14.43% | 34.90% | -69.02% | 126.89% | 161.73% |
| Total Other Current Liabilities | 14.43% | 34.90% | -69.02% | 126.89% | 161.73% |
| Total Current Liabilities | 38.63% | 29.59% | 81.39% | -34.69% | 112.71% |
|
|
|||||
| Total Current Liabilities | 38.63% | 29.59% | 81.39% | -34.69% | 112.71% |
| Long-Term Debt | -0.86% | 1.00% | -2.74% | 1.04% | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -18.92% | -15.53% | -13.10% | -11.27% | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 14.87% | 10.69% | 15.50% | -9.78% | 607.64% |
|
|
|||||
| Common Stock & APIC | 0.46% | 0.47% | 0.49% | 2.12% | 0.49% |
| Retained Earnings | -12.90% | -11.53% | -8.64% | -6.68% | -8.00% |
| Treasury Stock & Other | -109.27% | 415.85% | -13.89% | -146.15% | 161.30% |
| Total Common Equity | -16.29% | -10.96% | -6.90% | -1.85% | -4.75% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -16.29% | -10.96% | -6.90% | -1.85% | -4.75% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -16.29% | -10.96% | -6.90% | -1.85% | -4.75% |
|
|
|||||
